Aspects of Peptidomimetics - Peptide and Protein Design for Biopharmaceutical Applications - page 110

[88] C. G. Wang and H. I. Mosberg, Synthesis of a novel series of topographically
constrained amino-acids - benzo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids,
Tetrahedron Lett ., 36, 3623-3626 (1995).
[89] S. Van Cauwenberghe, J. Martins, M. Gosselin, L. Hodzic, J. Butterworth and
D. Tourw ´, Replacement of the Tic residue by benzo-1,2,3,4-tetrahydroisoquinoline-
3-carboxylic acids in TIPP peptides, In: Chorev, M. and Sawyer, T. K., Peptides.
Peptide Revolution: Genomics, Proteomics & Therapeutics. Proceedings of the 18th
American Peptide Symposium, 665-666, 2003.
[90] J. B. Thomas, R. N. Atkinson, N. A. Vinson, J. L. Catanzaro, C. L. Perretta, S. E. Fix, S.
W. Mascarella, R. B. Rothman, H. Xu, C. M. Dersch, B. E. Cantrell,
D. M. Zimmerman and F. I. Carroll, Identification of (3R)-7-hydroxy-N-((1S)-1-
{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-
1,2,3,4-tetrahydro-3-isoquinolinecarboxamide as a novel potent and selective opioid
kappa receptor antagonist, J.Med.Chem ., 46, 3127-3137 (2003).
[91] S. E. Gibson, N. Guillo, J. O. Jones, I. M. Buck, S. B. Kalindjian, S. Roberts and
M. J. Tozer, CCK2 receptor antagonists containing the conformationally constrained
phenylalanine derivatives, including the new amino acid Xic, Eur.J.Med.Chem ., 37,
379-389 (2002).
[92] R. Z. Cai, S. Radulovic, J. Pinski, A. Nagy, T. W. Redding, D. B. Olsen and
A. V. Schally, Pseudononapeptide bombesin antagonists containing C-terminal Trp
or Tpi, Peptides , 13, 267-271 (1992).
[93] Z. Darula, K. E. Kover, K. Monory, A. Borsodi, E. Mako, A. Ronai, D. Tourw ´,
A. Peter and G. Toth, Deltorphin II analogues with 6-hydroxy-2-aminotetralin-2-
carboxylic acid in position 1, J.Med.Chem ., 43, 1359-1366 (2000).
[94] S. Salvadori, S. D. Bryant, C. Bianchi, G. Balboni, V. Scaranari, M. Attila and
L. H. Lazarus, Phe(3)-substituted analogues of deltorphin-C - spatial conformation
and topography of the aromatic ring in peptide recognition by delta-opioid receptors,
J.Med.Chem ., 36, 3748-3756 (1993).
[95] G. Toth, Z. Darula, A. Peter, F. Fulop, D. Tourw ´, H. Jaspers, P. Verheyden, Z. Bocskey,
Z. Toth and A. Borsodi, Conformationally constrained deltorphin analogues with 2-ami-
notetralin-2-carboxylic acid in position 3, J.Med.Chem ., 40, 990-995 (1997).
[96] B. S. Vig, M. Q. Zheng, T. F. Murray and J. V. Aldrich, Effects of the substitution of
Phe(4) in the opioid peptide [ D -Ala(8)]dynorphin A-(1-11)NH 2 , J.Med.Chem ., 46,
4002-4008 (2003).
[97] X. J. Chu, D. Bartkovitz, W. Danho, J. Swistok, A. W. H. Cheung, G. Kurylko,
K. Rowan, M. Yeon, L. Franco, L. D. Qi, L. Chen and K. Yagaloff, Discovery of
1-amino-4-phenylcyclohexane-1-carboxylic acid and its influence on agonist selec-
tivity between human melanocortin-4 and -1 receptors in linear pentapeptides,
Bioorg . Med.Chem.Lett ., 15, 4910-4914 (2005).
[98] S. Oishi, R. G. Karki, S. U. Kang, X. Z. Wang, K. M. Worthy, L. K. Bindu,
M. C. Nicklaus, R. J. Fisher and T. R. Burke, Design and synthesis of conformation-
ally constrained Grb2 SH2 domain binding peptides employing alpha-methylpheny-
lalanyl based phosphotyrosyl mimetics, J.Med.Chem ., 48, 764-772 (2005).
[99] D. Obrecht, M. Altorfer, U. Bohdal, J. Daly, W. Huber, A. Labhardt, C. Lehmann, K.
Muller, R. Ruffieux, P. Schonholzer, C. Spiegler and C. Zumbrunn, Design and
synthesis of novel nonpolar host peptides for the determination of the 3(10)- and
alpha-helix compatibilities of alpha-amino acid building blocks: An assessment of
alpha,alpha-disubstituted glycines, Biopolymers , 42, 575-626 (1997).